- Home
- PESI vs SCPH Comparison
PESI vs SCPH Comparison
Compare PESI & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PESI
- SCPH
- Stock Information
- Founded
- PESI 1990
- SCPH 2013
- Country
- PESI United States
- SCPH United States
- Employees
- PESI N/A
- SCPH N/A
- Industry
- PESI Environmental Services
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- PESI Industrials
- SCPH Health Care
- Exchange
- PESI Nasdaq
- SCPH Nasdaq
- Market Cap
- PESI 205.4M
- SCPH 173.6M
- IPO Year
- PESI 1992
- SCPH 2017
- Fundamental
- Price
- PESI $11.63
- SCPH $4.60
- Analyst Decision
- PESI
- SCPH Strong Buy
- Analyst Count
- PESI 0
- SCPH 3
- Target Price
- PESI N/A
- SCPH $14.00
- AVG Volume (30 Days)
- PESI 139.2K
- SCPH 373.6K
- Earning Date
- PESI 08-07-2025
- SCPH 08-07-2025
- Dividend Yield
- PESI N/A
- SCPH N/A
- EPS Growth
- PESI N/A
- SCPH N/A
- EPS
- PESI N/A
- SCPH N/A
- Revenue
- PESI $60,019,000.00
- SCPH $49,969,000.00
- Revenue This Year
- PESI $23.71
- SCPH $108.95
- Revenue Next Year
- PESI $86.33
- SCPH $73.83
- P/E Ratio
- PESI N/A
- SCPH N/A
- Revenue Growth
- PESI N/A
- SCPH 107.79
- 52 Week Low
- PESI $6.25
- SCPH $1.94
- 52 Week High
- PESI $16.25
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- PESI 53.08
- SCPH 44.52
- Support Level
- PESI $11.28
- SCPH $4.13
- Resistance Level
- PESI $11.98
- SCPH $5.10
- Average True Range (ATR)
- PESI 0.63
- SCPH 0.36
- MACD
- PESI -0.01
- SCPH -0.11
- Stochastic Oscillator
- PESI 58.43
- SCPH 29.88
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.